Elliot Maza – President at Intellect Neurosciences, Inc.
Elliot Maza
Elliot Maza served as Interim and then Chief Executive Officer of Immune Pharmaceuticals, Inc. from May 2017 until August 2018, after serving as a Director since January 2015. He is a versatile and strategic seasoned executive with top-notch accounting, legal and investment banking skills.
Elliot Maza is a people leader and influencer known for his exceptional skills at fostering teamwork and achieving tangible results through collaboration, mentoring and application of technical expertise.
Elliot Maza is a builder of strong relationships with all stakeholders; possessor of an extensive network of connections in the life science community. He has great interpersonal and management skills.
Elliot Maza is proficient in designing and implementing strategic vision and business plans and presenting corporate strategy and goals. He is known for developing business plans, including plans for product development and regulatory pathways. He also assists in obtaining funding. He is a brilliant professional and his wide-ranging experience is a testimony to his extraordinary accomplishments.
Consulting
Elliot Maza is available to offer consultation in the following areas:
- Sourcing Capital
- Business Model Development
- Mergers & Acquisitions
- Corporate Development
- Technology Licensing Agreements
- IPOs (traditional/ “reverse merger”)
- Finance and Accounting
- Process Improvement
- Corporate Communications
- Regulatory Compliance
- FDA submissions
Speaking
Elliot Maza is available to talk about Sourcing Capital, Business Model Development, Mergers & Acquisitions, Corporate Development, Technology Licensing Agreements, and FDA submissions.